Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
1 |
Bergström M et al. |
Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant.
|
2 |
Erkolahti R et al. |
Body dysmorphic disorder of twins with facial illness after successful isotretinoin therapy.
|
3 |
Haapasalo-Pesu K-M. |
Studies on the Psychopharmacological Treatment of Adolescents in Finland.
|
4 |
Haapasalo-Pesu K-M et al. |
Prescription of psychotropic drugs in adolescent psychiatry wards in Finland.
|
5 |
Hagelberg N et al. |
Alfentanil increases cortical dopamine D2/D3 receptor binding in healthy subjects.
|
6 |
Hagelberg N et al. |
Striatal dopamine D2 receptors in modulation of pain in humans: a review.
|
7 |
Hakala M et al. |
Volumes of the caudate nuclei in women with somatization disorder and healthy women.
|
8 |
Heikkilä J et al. |
Psychodynamic personality profile in first-episode severe mental disorders.
|
9 |
Heikkilä J et al. |
Family functioning, expressed emotion and family type in families with a first-episode severe metal disorder patient.
|
10 |
Hietala J. |
Skitsofrenia aivojen kehityksen ja hermosolujen muovautuvuuden häiriönä.
|
11 |
Hirvonen M et al. |
C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo.
|
12 |
Honkonen T et al. |
Violent victimization in schizophrenia.
|
13 |
Hotti A. |
Mitä psykiatrinen potilas haluaa tietää? Tutkimus skitsofreniaan sairastuneiden tiedon saannista ja tarpeista.
|
14 |
Ilonen T et al. |
Neuropsychological subtyping of schizophrenia.
|
15 |
Iso-Koivisto E. |
"Pois sieltä, ylös, takaisin" - ensimmäinen psykoosi kokemuksena.
|
16 |
Koponen H, Hietala J. |
Psykoosilääkkeen valinnan kliinis-farmakologiset perusteet.
|
17 |
Koponen S et al. |
APOE-epsilon4 predicts dementia but not other psychiatric disorders after traumatic brain injury.
|
18 |
Kärkkäinen J. |
Onnistuiko psykiatrian yhdentyminen somaattiseen hoitojärjestelmään? Psykiatrisen hoitojärjestelmän kehitys Suomessa ja sairaanhoitopiiriuudistuksen arviointi psykiatrian näkökulmasta.
|
19 |
Leinonen E et al. |
Elderly patients with major depressive disorder and delusional disorder are at increased risk of subsequent dementia.
|
20 |
Lipsanen T. |
Dissociation as a Psychiatric Phenomenon.
|
21 |
Lipsanen T et al. |
Dissociative disorders among psychiatric patients. Comparison with a nonclinical sample.
|
22 |
Nieminen-von Wentdt TS et al. |
Increased presynaptic dopamine function in Asperger syndrome .
|
23 |
Penttilä J et al. |
Effects of fluoxetine on dopamine D2 receptors in the human brain: a positron emission tomography study with (11C)raclopride.
|
24 |
Pertovaara A et al. |
Striatal dopamine D2/D3 receptor availability correlates with individual response characteristics to pain.
|
25 |
Raitasalo R et al. |
Masennuspotilaiden elämänhallinta, toipuminen ja työkyky.
|
26 |
Saariluoma P et al. |
Visuospatial representations used by chess experts: A preliminary study.
|
27 |
Salmi E et al. |
Sevoflurane and propofol increase 11C-flumazenil binding to gamma-aminobutyric acidA receptors in humans.
|
28 |
Salokangas R. |
The developing psychiatry.
|
29 |
Salokangas RKR. |
Psychiatric specialist care in Finland - achievements and challenges.
|
30 |
Salokangas RKR. |
Gender and the use of neuroleptics in schizophrenia.
|
31 |
Salokangas RKR. |
Aistiharha - neurologinen vai psykiatrinen häiriö?
|
32 |
Salokangas RKR et al. |
Vulnerability to and current risk of psychosis.
|
33 |
Salokangas RKR, Suomela T. |
Psykoosin varhaistunnistaminen ja ensi vaiheen hoito.
|
34 |
Solin O et al. |
Synthesis and characterization of a potent, selective, radiolabeled substance-P antagonist for NK1 receptor quantitation: (18F)SPA-RQ).
|
35 |
Suomen Psykiatriyhdistys ry:n asettama työryhmä. |
Depressio.
|
36 |
Tiihonen J et al. |
Brain serotonin 1 A receptor binding in bulimia nervosa.
|